Stryker has signed a definitive agreement to acquire Amplitude Vascular Systems, a privately held medical technology company developing a next-generation intravascular lithotripsy platform designed to treat calcified peripheral arterial disease. Financial terms of the deal were not disclosed.
The acquisition strengthens Stryker’s Peripheral Vascular portfolio by adding revascularization technology. Once the product receives clearance for use in applicable markets, it will complement Stryker’s existing peripheral vascular offerings and support the company’s strategy to expand its presence in arterial disease treatment. Stryker trades on the NYSE under the ticker SYK.